- Home
- HMR vs ADAG Comparison
HMR vs ADAG Comparison
Compare HMR & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMR
- ADAG
- Stock Information
- Founded
- HMR 1984
- ADAG 2011
- Country
- HMR Greece
- ADAG China
- Employees
- HMR N/A
- ADAG N/A
- Industry
- HMR Marine Transportation
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- HMR Consumer Discretionary
- ADAG Health Care
- Exchange
- HMR Nasdaq
- ADAG Nasdaq
- Market Cap
- HMR 99.5M
- ADAG 90.8M
- IPO Year
- HMR N/A
- ADAG 2021
- Fundamental
- Price
- HMR $1.53
- ADAG $1.92
- Analyst Decision
- HMR Strong Buy
- ADAG Strong Buy
- Analyst Count
- HMR 2
- ADAG 1
- Target Price
- HMR $6.00
- ADAG $8.00
- AVG Volume (30 Days)
- HMR 137.0K
- ADAG 92.4K
- Earning Date
- HMR 06-10-2025
- ADAG 08-12-2025
- Dividend Yield
- HMR N/A
- ADAG N/A
- EPS Growth
- HMR N/A
- ADAG N/A
- EPS
- HMR N/A
- ADAG N/A
- Revenue
- HMR $26,159,037.00
- ADAG $103,204.00
- Revenue This Year
- HMR $6.54
- ADAG $9,289.17
- Revenue Next Year
- HMR $41.26
- ADAG $36.84
- P/E Ratio
- HMR N/A
- ADAG N/A
- Revenue Growth
- HMR N/A
- ADAG N/A
- 52 Week Low
- HMR $1.45
- ADAG $1.33
- 52 Week High
- HMR $10.04
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- HMR N/A
- ADAG 50.00
- Support Level
- HMR N/A
- ADAG $1.87
- Resistance Level
- HMR N/A
- ADAG $2.17
- Average True Range (ATR)
- HMR 0.00
- ADAG 0.16
- MACD
- HMR 0.00
- ADAG 0.01
- Stochastic Oscillator
- HMR 0.00
- ADAG 56.14
About HMR Heidmar Maritime Holdings Corp. Common Stock
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.